Skip to content

Effect of SSRI and SNRI on various mental activities including learning and problem solving among patients suffering from major depressive disorder

A prospective, observational study to assess the effects of SSRI and SNRI on cognitive function in patients of Major Depressive Disorders (MDD)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/06/014537
Enrollment
50
Registered
2018-06-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- All adult diagnosed patients of MDD as per ICD 10 criteria in remission phase

Interventions

None listed

Sponsors

Department of Pharmacology IPGMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Adult patients (18 years to 50 years) of either gender attending psychiatry OPD at IOP, with a clinical diagnosis of Major Depressive Disorder as per ICD10 criteria. 2)Subjects of MDD must be in remission phase with a Hamilton Depressive Rating Score (HAM-D 17) of 3)Subjects should have at least 8 years of formal school education in order to undertake the cognitive function tests. 4)Subjects or their care givers should be willing to give written informed.

Exclusion criteria

Exclusion criteria: 1)History of post traumatic or Obsessive compulsive Disorder (OCD) 2)History of schizophrenia, psychosis or bipolar delusional disorder 3)History of intake of any drugs that are likely to have effect on cognition (anticonvulsants, sedative hypnotics, neuroleptics, opioids) 4)History of addictions- alcohol, substance abuse

Design outcomes

Primary

MeasureTime frame
Changes in cognitive function scoreTimepoint: Attime points- 3, 6 and 9 months from the date of commencement of study.Both the absolute changes and percentage change from enrollment visit to 9 months visit shall be computed.

Secondary

MeasureTime frame
the nature of the changes in different domains of cognitive functions and to analyze whether there are any observable differences in the effects of the individual drugs on cognitive function.Timepoint: At time points- 3, 6 and 9 months from the date of commencement of study.

Countries

India

Contacts

Public ContactDr Suparna Chatterjee

Department Of Pharmacology Institute of Post Graduate Medical Education and Research

drsupchat@gmail.com9831130980

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026